Clearmind Medicine (CMND) - 2023 Q1 - Quarterly Report

c. Significant Accounting Estimates and Judgments (continued) Significant Judgments 3. Short-term Investment CLEARMIND MEDICINE INC. Notes to the Condensed Interim Consolidated Financial Statements (Expressed in Canadian Dollars) (Unaudited) a. Compensation to key management personnel | --- | --- | --- | |---------------------------------|-------|-------| | | | | | Amounts owed to officers | | | | | | | | Amounts owed to directors | | | CLEARMIND MEDICINE INC. (iii) During the three months ended January 31, ...